Search results
COVID cases rising in L.A. County and California as new subvariants make mark
Los Angeles Times· 6 days agoCalifornia’s COVID-19 numbers are on the rise thanks in part to new subvariants, suggesting an...
12 recent scientific breakthroughs
The Week via Yahoo News· 10 hours ago"And, if we do find signs of life elsewhere, we can tell if life on Earth and other planets derived from a common or different origin." 9. Inverse ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Washington conducted secret global anti-vaccine disinformation campaign against China
World Socialist Web Site· 2 days agoAn investigative report published by Reuters on June 14 revealed that the Pentagon conducted a...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days ago12 a share. The company noted that it achieved 48% market share for Covid vaccines in the U.S....
U.S. military caught running secret vaccine smear campaign
Boing Boing· 4 days agoThe U.S. military launched a clandestine operation to undermine trust in China's COVID-19 vaccines,...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 5 days agoThe company is working to cut costs, but it has an uphill battle. Over the trailing 12 months, it incurred a net loss totaling $399 million. Have you...
UFC figures have found a home for their bigotry and conspiracy theories in right-wing media
Media Matters· 5 days agoRight-wing media have amplified conspiracy theories and bigotry from Ultimate Fighting Championship...
What Makes Big Pharma’s Blockbuster Product So Dangerous?
Mercola· 5 days ago1. Immune dysfunction — Vaccines frequently cause chronic autoimmune disorders and varying degrees of immune suppression. 3. Impaired circulation — Vaccines
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 7 days agoIndeed, from a forecast standpoint, the near future looks bright. While revenue will witness only mild growth in the next four years, Ebitda is estimated...
